B Cells, T Cells and Inflammatory CSF Biomarkers in Primary Progressive MS and Relapsing MS in the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Trial Bar-Or, A., Bennett, J., Von Budingen, H., Carruthers, R., Edwards, K., Fallis, R., Fiore, D., Gelfand, J., Giacomini, P., Greenberg, B., Hafler, D., Longbrake, E., Assman, B., Ionete, C., Kaunzner, U., Lock, C., Ma, X., Musch, B., Pardo, G., Pei, J., Piehl, F., Weber, M., Ziemssen, T., Herman, A., Harp, C., Cross, A. LIPPINCOTT WILLIAMS & WILKINS. 2020

View details for Web of Science ID 000536058003079